CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.
CLINICAL GUIDELINE (English) CLINICAL GUIDELINE (French)
OPERATIONAL GUIDANCE (English) OPERATIONAL GUIDANCE (French)
A synopsis of the Guideline was published in the Canadian Medical Association Journal
A podcast was also produced by CMAJ, which can be found at the link above.
You can also access the Guideline Development Methodology (as supplied by the authors) here
SUPPLEMENTAL MATERIALS
Supervised Consumption Sites vs iOAT
Sample Program Expectations
Sample Patient Bill of Rights
Sample Client Safety Care Plan
Sample Treatment Plan
Sample Floor Plan
Lessons Learned
FAQ for Patients and Families
Case Studies
Sample Diacetylmorphine Titration Pre-Printed Order
Sample Hydromorphone Titration Pre-Printed Order
Sample Hydromorphone Titration Hospital Pre-Printed Order Package
Sample Hydromorphone Maintenance Pre-Printed Order
Journal Article: Perspectives of people with opioid use disorder on improving addiction treatments and services (Lachapelle, et al, 2020)